Evidence map›Paper›PMID 35740368›Full record

ArticleBiomedicines2022

Urokinase-Type Plasminogen Activator Enhances the Neuroprotective Activity of Brain-Derived Neurotrophic Factor in a Model of Intracerebral Hemorrhage.

Stalik Dzhauari, Svetlana Litvinova, Anastasia Efimenko, Natalia Aleksandrushkina, Nataliya Basalova, Maxim Abakumov, Natalia Danilova, Pavel Malkov, Vadim Balabanyan, Tatiana Bezuglova and 9 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Stalik DzhauariFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.
Svetlana LitvinovaFederal State Budgetary Institution "Research Zakusov Institute of Pharmacology", 8, Baltiyskaya Str., 125315 Moscow, Russia.
Anastasia EfimenkoFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.ORCID 0000-0002-0696-1369
Natalia AleksandrushkinaFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.ORCID 0000-0003-4946-7843
Nataliya BasalovaFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.ORCID 0000-0002-2597-8879
Maxim AbakumovDepartment of Medical Nanobiotechnology, National University of Science and Technology MISiS, 4, Leninskiy Ave., 119049 Moscow, Russia.
Natalia DanilovaMedical Research and Education Center, Lomonosov Moscow State University, 27/10, Lomonosovsky Ave., 119192 Moscow, Russia.
Pavel MalkovMedical Research and Education Center, Lomonosov Moscow State University, 27/10, Lomonosovsky Ave., 119192 Moscow, Russia.
Vadim BalabanyanFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.
Tatiana BezuglovaResearch Institute of Human Morphology, 3, Tsyurupy Str., 117418 Moscow, Russia.ORCID 0000-0001-7792-1594
Viktor BalayantsResearch Institute of Human Morphology, 3, Tsyurupy Str., 117418 Moscow, Russia.
Maxim MnikhovichResearch Institute of Human Morphology, 3, Tsyurupy Str., 117418 Moscow, Russia.
Mikhail GulyaevFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.ORCID 0000-0003-4684-2484
Mariya SkryabinaFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.
Vladimir PopovFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.ORCID 0000-0002-5039-7152
Dmitry StambolskyMedical Research and Education Center, Lomonosov Moscow State University, 27/10, Lomonosovsky Ave., 119192 Moscow, Russia.ORCID 0000-0001-6983-9697
Tatiana VoroninaFederal State Budgetary Institution "Research Zakusov Institute of Pharmacology", 8, Baltiyskaya Str., 125315 Moscow, Russia.
Vsevolod TkachukFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.
Maxim KaragyaurFaculty of Medicine, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.ORCID 0000-0003-4289-3428
Lomonosov Moscow State University · RUResearch Institute of Human Morphology · RUInstitute of Pharmacology Russian Academy of Medical Sciences · RUNational University of Science and Technology · RU

Funding

Russian Foundation for Basic Research 18-015-00535
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) is a classic neuroprotective and pro-regenerative factor in peripheral and central nervous tissue. Its ability to stimulate the restoration of damaged nerve and brain tissue after ischemic stroke and intraventricular hemorrhage has been demonstrated. However, the current concept of regeneration allows us to assert that one factor, even if essential, cannot be the sole contributor to this complex biological process. We have previously shown that urokinase-type plasminogen activator (uPA) complements BDNF activity and stimulates restoration of nervous tissue. Using a model of intracerebral hemorrhage in rats, we investigated the neurotrophic and neuroprotective effect of BDNF combined with uPA. The local simultaneous administration of BDNF and uPA provided effective neuroprotection of brain tissue after intracerebral hemorrhage, promoted survival of experimental animals and their neurological recovery, and decreased lesion volume. The study of cellular mechanisms of the observed neurotrophic effect of BDNF and uPA combination revealed both known mechanisms (neuronal survival and neurite growth) and new ones (microglial activation) that had not been shown for BDNF and uPA. Our findings support the concept of using combinations of biological factors with diverse but complementary mechanisms of action as a promising regenerative approach.

Indexed as

brain-derived neurotrophic factorglutamate-induced neurotoxicityintracerebral hemorrhagemicroglia activationstrokeurokinase plasminogen activator

Identifiers

PMID35740368
PMCPMC9220139
OpenAlexW4281640880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.